Zimmer Biomet Dividend Declared, QSM Boosts Stake

Ed Don | January 1, 2026 | 0

Snack-Sized Version:

Zimmer Biomet recently declared a quarterly dividend of $0.24 per share. This news comes as QSM Asset Management increased its stake in the company by 17.9%. As a result, Zimmer Biomet is now the fund’s largest holding. The company also recently posted earnings of $1.90 per share, which beat analyst estimates. However, revenue of $2.0 billion slightly missed expectations, although it grew 9.6% year-over-year. Furthermore, the company set its full-year 2025 EPS guidance between $8.10 and $8.30. Overall, analyst sentiment remains mixed with a consensus “Hold” rating on the stock.

Dividend Snapshot
Dividend amount	$0.24 per share (quarterly)
Ex-date	December 30th
Yield	Represents a ~1.1% annualized yield
Signal	Provides a consistent income return to shareholders

Source: Company dividend announcement.

Read the Full Meal:

Zimmer Biomet announced a quarterly dividend of $0.24 per share for investors. The ex-dividend date for this payment was December 30th. In addition, this news follows a significant move by QSM Asset Management. The fund lifted its stake in Zimmer Biomet by 17.9% during the third quarter. Consequently, the stock is now QSM’s largest position, making up 9.2% of its portfolio. The company also reported third-quarter earnings of $1.90 per share, beating consensus estimates. However, Wall Street analysts maintain a mixed view on the stock. The consensus rating is currently a “Hold” among research firms.

Zimmer Biomet Declares Dividend Amid Institutional Buying

Institutional Stake: QSM Asset Management increased its holdings by 19,950 shares, making ZBH its largest position.
Recent Earnings: The company reported Q3 EPS of $1.90, which topped consensus estimates of $1.88.
Revenue Growth: Quarterly revenue grew 9.6% year-over-year to $2.0 billion, but it slightly missed analyst forecasts.
Analyst Consensus: Analysts assign the stock an average rating of “Hold” with a consensus price target of $107.50.

Why this can matter for NYSE:ZBH holders

Shareholder Returns: The company’s consistent quarterly dividend provides a direct cash return to its investors.
Institutional Confidence: A major fund increasing its position could signal confidence in the company’s long-term value.
Mixed Outlook: However, numerous price target cuts and a “Hold” rating suggest analysts see limited near-term upside.

For more details, see ZBH SEC filings.

What to watch next

Dividend Payment: The declared dividend is scheduled to be paid to shareholders of record on January 30th.
Next Earnings Report: Investors should monitor the company’s next quarterly earnings release for updated performance data.
Analyst Revisions: Watch for further analyst price target updates following recent performance and guidance.

Mini FAQ

What was Zimmer Biomet’s recent dividend announcement?
The company announced a quarterly dividend of $0.24 per share. This represents an annualized dividend of $0.96. As a result, it provides a yield of about 1.1%.

How did Zimmer Biomet perform in its latest earnings report?
Zimmer Biomet reported earnings of $1.90 per share, which beat estimates. In addition, its revenue was $2.0 billion. This figure was up 9.6% year-over-year.

What is the current analyst sentiment on ZBH stock?
The consensus rating from analysts is currently “Hold”. However, one analyst has a “Strong Buy” rating. The average price target is set at $107.50.